Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Genetic variations linked to declines in blood oxygen levels during sleep identified

Researchers have identified 57 genetic variations of a gene strongly associated with declines in blood oxygen levels during sleep. Low oxygen levels during sleep are a clinical indicator of the severity of sleep apnea, a disorder that increases the risk of heart disease, dementia, and death.

24 Oct 2019

Mayo Clinic study explores patient privacy in MRI research

Though identifying data typically are removed from medical image files before they are shared for research, a Mayo Clinic study finds that this may not be enough to protect patient privacy.

24 Oct 2019

Detecting neurotransmitters at the lowest concentrations

Dopamine, serotonin, adrenalin... The smooth functioning of the human brain depends on their correct proportions. Any disturbances mean diseases.

24 Oct 2019

Researchers receive $9.7 million NIH grant to study TBI and neurodegenerative diseases

An international team of experts led by researchers in the Perelman School of Medicine at the University of Pennsylvania and University of Glasgow has been awarded a $9.7 million, five-year grant from the National Institute of Neurological Disorders and Stroke and National Institute for Aging to establish CONNECT-TBI--a program spanning 12 institutions which will study traumatic brain injury and related neurodegenerative diseases.

24 Oct 2019

New NPO formed to accelerate development of therapies for Shankopathies

Parents of children affected by Phelan-McDermid syndrome (PMS) announce the formation of CureSHANK, a nonprofit organization on a mission to accelerate drug development in PMS and other diseases related to the SHANK genes for which there are currently no FDA approved treatments.

23 Oct 2019

Novel agent reduces buildup of toxic proteins in Parkinson's and Alzheimer's animal models

Neuroscientists at Georgetown University Medical Center say they have developed and tested an agent that reduces the buildup of toxic proteins in animal models of both Parkinson's and Alzheimer's diseases, and improves cognitive and motor behavior.

23 Oct 2019

NIA-funded study to examine overall benefits and risks of statins in older adults

The National Institute on Aging has funded a major study to examine the overall benefits and risks of cholesterol-lowering drugs known as statins in adults age 75 or older without cardiovascular disease.

23 Oct 2019

High levels of dietary salt can activate a brain pathway to cause cognitive impairment

High levels of dietary salt can activate a pathway in the brain to cause cognitive impairment, according to a new study. The paper, which was published in Nature, shows that this effect is not due to a loss in blood flow to the brain as originally thought, but rather to clumps of a protein linked to several forms of dementia in humans.

23 Oct 2019

Highest anxiety and sleeping pill prescription rates in deprived areas of England

The poorest and most socially deprived areas in England have the highest rates of prescription for benzodiazepines and Z-drugs, according to a new University of Warwick study published in the journal Family Practice on October 22, 2019.

23 Oct 2019

Discovery sheds light on TNFα protein's role in impairing memory in Alzheimer's disease

Otago scientists have made an important discovery in understanding the role a particular protein plays to impair memory in Alzheimer's disease, which could lead to more effective treatment in future.

23 Oct 2019

UCLA-led study finds brain injury as cause of dementia in some older adults

A UCLA-led study finds that, with the use of MRI scans, it is possible to distinguish between memory loss caused by Alzheimer's disease and traumatic brain injury.

23 Oct 2019

SARA robots could help improve elderly care in nursing homes and hospitals

The rapidly ageing population is bringing new challenges to European society. Care institutions and hospitals are facing serious staffing shortages, as fewer and fewer people choose to become healthcare professionals, while at the same time the number of old (and sick) people is constantly on the rise.

23 Oct 2019

Half the drugs in use damage gut bacteria, says new study

A startling presentation at UEG Week 2019, in Barcelona, reveals that the gut microbiome is at high risk for damage each time we use a drug from one or more of 18 commonly used groups. The effects may range from changes in the relative proportions of different beneficial and potentially harmful species to alterations in the cellular metabolism of the bacteria themselves.

23 Oct 2019

Dementia patients’ adult kids develop symptoms six years earlier than their parents

A person's chance of developing dementia is influenced by family history, variations in certain genes, and medical conditions such as cardiovascular disease and diabetes. But less is known about the factors that affect when the first symptoms of forgetfulness and confusion will arise.

22 Oct 2019

More brain pathology and hospitalizations associated with faster rate of cognitive decline

Older people who experienced more hospitalizations and also had more Alzheimer's pathology in their brain experienced the fastest rates of cognitive decline, according to study results published in the October 15 online issue of the Annals of Neurology.

22 Oct 2019

Researchers receive $3.2 million NIH grant to pursue a deeper understanding of Down syndrome

Mount Sinai researchers have been awarded a $3.2 million grant from the National Institutes of Health to pursue a deeper understanding of Down syndrome, the most common genetic cause of intellectual and developmental disabilities in children and young adults, affecting more than 200,000 individuals in the United States.

22 Oct 2019

Biogen to pursue FDA regulatory approval for investigational drug aducanumab

On behalf of the more than 5 million Americans living with Alzheimer's and their family members, the Alzheimer's Association is encouraged to learn that Biogen will pursue regulatory approval from the FDA for the investigational drug aducanumab based on Phase 3 clinical trial results from the EMERGE and ENGAGE studies, and other related data, after finding a reduction of cognitive and functional decline in people taking the high dose.

22 Oct 2019

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Genetic variations linked to declines in blood oxygen levels during sleep identified

Mayo Clinic study explores patient privacy in MRI research

Detecting neurotransmitters at the lowest concentrations

Researchers receive $9.7 million NIH grant to study TBI and neurodegenerative diseases

New NPO formed to accelerate development of therapies for Shankopathies

Novel agent reduces buildup of toxic proteins in Parkinson's and Alzheimer's animal models

NIA-funded study to examine overall benefits and risks of statins in older adults

High levels of dietary salt can activate a brain pathway to cause cognitive impairment

Highest anxiety and sleeping pill prescription rates in deprived areas of England

Discovery sheds light on TNFα protein's role in impairing memory in Alzheimer's disease

UCLA-led study finds brain injury as cause of dementia in some older adults

SARA robots could help improve elderly care in nursing homes and hospitals

Half the drugs in use damage gut bacteria, says new study

Dementia patients’ adult kids develop symptoms six years earlier than their parents

More brain pathology and hospitalizations associated with faster rate of cognitive decline

Researchers receive $3.2 million NIH grant to pursue a deeper understanding of Down syndrome

Biogen to pursue FDA regulatory approval for investigational drug aducanumab

Study to examine whether cancer and co-occurring Alzheimer's alter pain perception

Salk Institute scientists receive NIH grant to better understand the brain

Researchers use mouse model to better understand mechanism involved in atrial fibrillation

Innovation in neuroscience drug discovery - eBook eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in